INTELLIA THERAPEUTICS, INC. Total Contract Liability
INTELLIA THERAPEUTICS, INC. (NTLA) had Total Contract Liability of $0 as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ContractWithCustomerLiability · last filed 2026-08-06
- 2026-06-30: Contract with Customer, Liability $0.00.
- 2026-03-31: Contract with Customer, Liability $630.00K.
- 2025-12-31: Contract with Customer, Liability $7.29M.
- 2025-09-30: Contract with Customer, Liability $24.79M.
| Period end | Contract with Customer, Liability |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 |
| 2026-03-31 | $630.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $7.29M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $24.79M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $29.69M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $33.82M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $38.92M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $44.76M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $50.24M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $55.62M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $60.99M 10-K · filed 2026-02-26 |
| 2023-09-30 | $26.07M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $34.85M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $49.20M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $63.77M 10-K · filed 2025-02-27 |
| 2022-09-30 | $80.50M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $97.14M 10-Q · filed 2023-08-03 |
| 2022-03-31 | $113.24M 10-Q · filed 2023-05-04 |
| 2021-12-31 | $127.23M 10-K · filed 2024-02-22 |
| 2021-09-30 | $119.78M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $62.75M 10-Q · filed 2022-08-04 |
| 2021-03-31 | $68.37M 10-Q · filed 2022-05-05 |
| 2020-12-31 | $73.93M 10-K · filed 2023-02-23 |
| 2020-09-30 | $79.61M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $100.68M 10-Q · filed 2021-08-05 |
| 2020-03-31 | $25.66M 10-Q · filed 2021-05-06 |
| 2019-12-31 | $28.81M 10-K · filed 2022-02-24 |
| 2019-09-30 | $35.14M 10-Q · filed 2020-11-05 |
| 2019-06-30 | $42.16M 10-Q · filed 2020-08-06 |
| 2019-03-31 | $49.09M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $55.93M 10-K · filed 2021-02-26 |
| 2018-09-30 | $46.26M 10-Q · filed 2019-10-31 |
| 2018-06-30 | $50.86M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $55.39M 10-Q · filed 2019-05-02 |
| 2017-12-31 | $59.87M 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |